Holen Sie sich die Stockscreener-App
23.19
3.25%
0.73
Handel nachbörslich:
23.19
Artivion Inc Aktie (AORT) Neueste Nachrichten
Artivion Q1 earnings call highlights - MSN
Artivion secures FDA approval for NEXUS aortic arch system - MSN
Artivion (AORT) Q1 earnings and revenues surpass estimates - MSN
Artivion (AORT) director corrects details of restricted stock award - Stock Titan
Artivion (AORT) director receives 7,576-share equity RSA grant - Stock Titan
Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System - MedTech Intelligence
Artivion (NYSE:AORT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of - Yahoo Finance
Artivion (AORT) director receives 7,850-share stock award, now holds 56,938 - Stock Titan
Artivion Earnings Call Balances Growth With Caution - TipRanks
Artivion closes Endospan buyout to acquire recently approved heart device - MedTech Dive
Artivion Bets On Full Aortic Arch Suite After Endospan Deal - Yahoo Finance
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition - MSN
Artivion (AORT) Completes Acquisition of Endospan for Aortic Sol - GuruFocus
Artivion Closes $175 Million Acquisition of Endospan - Moomoo
Artivion Completes Acquisition of Endospan, Secures FDA Approval for NEXUS Aortic Arch System - Minichart
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition - MSN
Artivion Closes $175M Deal for Aortic Arch Maker Endospan - Medical Product Outsourcing
Artivion completes $175M acquisition of Endospan - Investing.com UK
Artivion completes $175M acquisition of Endospan By Investing.com - Investing.com South Africa
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System - BioSpace
Artivion Closes Endospan Acquisition Following FDA Approval of NEXUS Aortic System - citybiz
Artivion completes $135 million Endospan acquisition - Investing.com
Artivion completes $135 million Endospan acquisition By Investing.com - Investing.com Australia
Artivion Completes Strategic Acquisition of Endospan Platform - TipRanks
Artivion completes acquisition of Endospan; $131.3M net upfront, up to $200M contingent - TradingView
Endospan acquisition gives Artivion (NYSE: AORT) FDA-approved NEXUS aortic arch system - Stock Titan
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS - Business Wire
Aortic surgery firm Artivion buys Endospan, NEXUS arch stent maker - Stock Titan
Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding - The Motley Fool
Artivion Q1 2026 Earnings: Revenue Matches Estimates, EPS Misses by 35%News and Statistics - IndexBox
5 Insightful Analyst Questions From Artivion’s Q1 Earnings Call - Yahoo Finance
Artivion, Inc. (NYSE:AORT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Artivion shareholders elect directors and approve executive compensation By Investing.com - Investing.com Nigeria
Artivion shareholders elect directors and approve executive compensation - Investing.com
Artivion Shareholders Back Board, Pay and Auditor Choices - TipRanks
Artivion (AORT) shareholders approve directors, executive pay and Ernst & Young for 2026 - Stock Titan
UBS Group AG Has $12.76 Million Position in Artivion, Inc. $AORT - MarketBeat
Artivion Inc (AORT) Shares Surge 3.1% -- What GF Score of 86 Tel - GuruFocus
Artivion Inc (AORT) Shares Surge 3.1% -- What GF Score of 86 Tells Investors - GuruFocus
Artivion (AORT) price target decreased by 16.86% to 43.73 - MSN
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):